简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Centogene因不合规而收到纳斯达克通知

2024-08-08 15:31

  • Centogene (NASDAQ:CNTG) received a notice from the Nasdaq indicating that the Nasdaq Hearings Panel has determined to delist stock.
  • The notice indicates that Centogene (CNTG) remains noncompliant with Nasdaq, which requires a minimum $15M market value of publicly held shares.
  • The company may, within 15 calendar days from the date of the notice, request that Nasdaq review the decision, but the company does not intend to make such a request.
  • As previously announced, the company’s plan to regain compliance related to the company completing a sale transaction by no later than August 26, 2024.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。